← Open Payments lookup

STACY GRIFFIN: Open Payments

NPI 1245952530 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$370 in 22 payments from 9 companies in 2025. Trend: 2023 $710 · 2024 $508 · 2025 $370

Food & beverage: $287Education: $83
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$141
Axsome Therapeutics, Inc.3$68
Janssen Pharmaceuticals, Inc2$44
ABBVIE INC.1$29
Otsuka America Pharmaceutical, Inc.1$21
Corium, LLC1$19
Takeda Pharmaceuticals U.S.A., Inc.1$17
Supernus Pharmaceuticals, Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: FANAPT, Auvelity, SPRAVATO, VRAYLAR, REXULTI, Azstarys, TRINTELLIX, Qelbree.

Industry payments across IN — which companies pay providers there.